Clinical Trials Logo

Clinical Trial Summary

Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a distinct disease entity with an estimated prevalence of 0.3-0.7% and more common in women (3:1 ratio). It can be diagnosed according to the Institute of Medicine (IOM) 2015 consensus definition using 3 major criteria and one of 2 minor criteria. Diagnosis requires that the patient have the following three symptoms: 1. A substantial reduction or impairment in the ability to engage in pre-illness levels of occupational, educational, social, or personal activities that persists for more than 6 months and is accompanied by fatigue, which is often profound, is of new or definite onset (not lifelong), is not the result of ongoing excessive exertion, and is not substantially alleviated by rest, 2. Post-exertional malaise,* and 3. Unrefreshing sleep* At least one of the two following manifestations is also required: 1. Cognitive impairment* or 2. Orthostatic intolerance Note* Frequency and severity of symptoms should be assessed. The diagnosis of ME/CFS should be questioned if patients do not have these symptoms at least half of the time with moderate, substantial, or severe intensity. Currently, individually tailored therapy with emphasis on cognitive behavioral therapy and graduated activity therapy is considered the therapy of first choice, although their effectiveness has been critically questioned in recent years. There are often frustrating treatment courses, a larger proportion of partial remissions, a significantly smaller proportion of full remissions and return to work. The study aims to evaluate patients of the outpatient service for chronic fatigue at the Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, Switzerland, in the context of a group therapy for the treatment of CFS/ME in respect to the response to different, non-drug based therapeutic procedures and to gain knowledge about the effects of the therapy. The study is a clinical comparative study of therapeutic procedures/interventions without the use of drugs or a medical product. The interventions are Acceptance Commitment Therapy (ACT) and Micro Breaks in Everyday Life (MBEL) adapted to CFS/ME. The collection of biological samples (saliva, blood) and health-related personal data (actigraphy, psychometric data from questionnaires) is associated with minimal risks and burdens.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05168124
Study type Interventional
Source University of Zurich
Contact Sarah Schiebler, MD
Phone 0041 255 52 80
Email sarah.schiebler@usz.ch
Status Recruiting
Phase N/A
Start date August 8, 2023
Completion date July 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05899595 - Effects of a Personalized Physical Training to Reduce Fatigue N/A
Not yet recruiting NCT01154647 - Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes N/A
Completed NCT00375973 - Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome Phase 2/Phase 3
Completed NCT02499302 - Mental Training for CFS Following EBV Infection in Adolescents N/A
Completed NCT02156128 - Subjective Memory Complaints, Objective Memory Performance and Cognitive Training N/A
Not yet recruiting NCT06386133 - Chronic Fatigue in Multiple Sclerosis: MS Copilot Boost Solution Compared to Standard Care N/A
Not yet recruiting NCT05116657 - Obstructive Sleep Apnoea Post Covid 19: Role of the Upper Airway Microbiome
Completed NCT00788918 - Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS) N/A
Completed NCT04435002 - The Effect of Acupressure on Fatigue in Individuals With Chronic Fatigue Syndrome N/A
Recruiting NCT05778006 - Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (ME/CFS) Registry and Biobank, COVID-19, SARS-CoV-2
Recruiting NCT06253026 - Fatigue in Air Search and Rescue Missions
Completed NCT00001415 - Glucocorticoid Effects on Cellular Cytokine Release N/A
Completed NCT04797871 - Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19 N/A
Recruiting NCT04049331 - Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone Phase 2
Completed NCT02335437 - Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents N/A
Recruiting NCT05728918 - Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People N/A
Completed NCT04833673 - The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial N/A
Recruiting NCT04947488 - Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital N/A
Recruiting NCT05840237 - REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID N/A
Active, not recruiting NCT04104750 - The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,